Download PDF
Semin Thromb Hemost 2017; 43(06): 621-628
DOI: 10.1055/s-0037-1603358
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Serum Concentration of Growth Differentiation Factor-15 Is Independently Associated with Global Platelet Function and Higher Fibrinogen Values in Adult Healthy Subjects

Giuseppe Lippi
1   Section of Clinical Biochemistry, University of Verona, Verona, Italy
,
Gian Luca Salvagno
1   Section of Clinical Biochemistry, University of Verona, Verona, Italy
,
Elisa Danese
1   Section of Clinical Biochemistry, University of Verona, Verona, Italy
,
Giorgio Brocco
1   Section of Clinical Biochemistry, University of Verona, Verona, Italy
,
Matteo Gelati
1   Section of Clinical Biochemistry, University of Verona, Verona, Italy
,
Martina Montagnana
1   Section of Clinical Biochemistry, University of Verona, Verona, Italy
,
Fabian Sanchis-Gomar
2   Department of Physiology, Instituto de Investigación INCLIVA, University of Valencia and Fundación Investigación Hospital Clínico Universitario de Valencia, Valencia, Spain
3   Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, New York
,
Emmanuel J. Favaloro
4   Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
08 June 2017 (online)

    Permissions and Reprints

Abstract

Growth differentiation factor-15 (GDF-15) has recently emerged as a strong and independent predictor of cardiovascular events and mortality. However, the pathophysiological mechanisms underlying this important association remain speculative. This study was aimed to investigate the potential associations between the serum concentration of GDF-15 and clinical or laboratory parameters in a population of ostensibly healthy subjects. The study population consisted of 44 healthy volunteers enrolled from the laboratory staff (14 males and 30 females; mean age, 47 ± 11 years), who had their blood collected for assessing complete blood cell count, GDF-15, serum creatinine, albumin, cardiac troponin T, galectin-3, routine coagulation tests, D-dimer, von Willebrand factor, and platelet function testing using platelet function analyzer-100. In univariate analysis, serum GDF-15 was found to be positively associated with age and plasma fibrinogen, and negatively associated with renal function and collagen-epinephrine (CEPI). In multiple linear regression analysis, serum GDF-15 remained significantly associated with renal function, CEPI, and plasma fibrinogen. Healthy subjects with GDF-15 above the median value had a twofold probability of displaying shorter CEPI closure times. Taken together, these results suggest that higher serum values of GDF-15 may be associated with overall global platelet hyperactivity and increased plasma fibrinogen, so providing another plausible explanation for the association between GDF-15, cardiovascular events, and mortality.

Keywords

growth differentiation factor-15 - GDF-15 - cardiovascular disease - platelets - PFA-100
 

  • References

  • 1 Benjamin EJ, Blaha MJ, Chiuve SE. , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation 2017; 135 (10) e146-e603
    CrossrefPubMedGoogle Scholar
  • 2 Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med 2016; 4 (13) 256
    CrossrefPubMedGoogle Scholar
  • 3 GeneCards. GDF15 gene. Available at: http://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF15 . Accessed March 15, 2017
    PubMedGoogle Scholar
  • 4 Sanchis-Gomar F, Bonaguri C, Aloe R. , et al. Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers. Transl Res 2013; 162 (02) 102-109
    CrossrefPubMedGoogle Scholar
  • 5 Fairlie WD, Zhang H, Brown PK, Russell PK, Bauskin AR, Breit SN. Expression of a TGF-beta superfamily protein, macrophage inhibitory cytokine-1, in the yeast Pichia pastoris. Gene 2000; 254 (1-2): 67-76
    CrossrefPubMedGoogle Scholar
  • 6 Corre J, Hébraud B, Bourin P. Concise review: growth differentiation factor 15 in pathology: a clinical role?. Stem Cells Transl Med 2013; 2 (12) 946-952
    CrossrefPubMedGoogle Scholar
  • 7 Wollert KC, Kempf T, Wallentin L. Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem 2017; 63 (01) 140-151
    CrossrefPubMedGoogle Scholar
  • 8 Gerstein HC, Pare G, Hess S. , et al; ORIGIN Investigators. Growth differentiation factor 15 as a novel biomarker for metformin. Diabetes Care 2017; 40 (02) 280-283
    CrossrefPubMedGoogle Scholar
  • 9 Yang MH, Kim J, Khan IA, Walker LA, Khan SI. Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anti-cancer agents. Life Sci 2014; 100 (02) 75-84
    CrossrefPubMedGoogle Scholar
  • 10 Schlittenhardt D, Schober A, Strelau J. , et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 2004; 318 (02) 325-333
    CrossrefPubMedGoogle Scholar
  • 11 Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study. Circulation 2011; 123 (19) 2101-2110
    CrossrefPubMedGoogle Scholar
  • 12 Wallentin L, Zethelius B, Berglund L. , et al. GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men. PLoS One 2013; 8 (12) e78797
    CrossrefPubMedGoogle Scholar
  • 13 Meune C, Balmelli C, Twerenbold R. , et al. Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin. Int J Cardiol 2013; 167 (04) 1164-1169
    CrossrefPubMedGoogle Scholar
  • 14 Zhang S, Dai D, Wang X. , et al. Growth differentiation factor-15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis. BMC Cardiovasc Disord 2016; 16: 82
    CrossrefPubMedGoogle Scholar
  • 15 George M, Jena A, Srivatsan V, Muthukumar R, Dhandapani VE. GDF 15--A novel biomarker in the offing for heart failure. Curr Cardiol Rev 2016; 12 (01) 37-46
    CrossrefPubMedGoogle Scholar
  • 16 Zeng X, Li L, Wen H, Bi Q. Growth-differentiation factor 15 as a predictor of mortality in patients with heart failure: a meta-analysis. J Cardiovasc Med (Hagerstown) 2017; 18 (02) 53-59
    CrossrefPubMedGoogle Scholar
  • 17 Lankeit M, Kempf T, Dellas C. , et al. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med 2008; 177 (09) 1018-1025
    CrossrefPubMedGoogle Scholar
  • 18 Duran L, Kayhan S, Guzel A. , et al. The prognostic values of GDF-15 in comparison with NT-proBNP in patients with normotensive acute pulmonary embolism. Clin Lab 2014; 60 (08) 1365-1371
    PubMedGoogle Scholar
  • 19 Hijazi Z, Oldgren J, Lindbäck J. , et al; ARISTOTLE and RE-LY Investigators. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet 2016; 387 (10035): 2302-2311
    CrossrefPubMedGoogle Scholar
  • 20 Hagström E, James SK, Bertilsson M. , et al; PLATO Investigators. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study. Eur Heart J 2016; 37 (16) 1325-1333
    CrossrefPubMedGoogle Scholar
  • 21 Pasalic L, Wang SS, Chen VM. Platelets as biomarkers of coronary artery disease. Semin Thromb Hemost 2016; 42 (03) 223-233
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Montoro-García S, Schindewolf M, Stanford S, Larsen OH, Thiele T. The role of platelets in venous thromboembolism. Semin Thromb Hemost 2016; 42 (03) 242-251
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Lippi G. Genetic and nongenetic determinants of mean platelet volume. Blood 2016; 127 (02) 179-180
    CrossrefPubMedGoogle Scholar
  • 24 Rossaint J, Vestweber D, Zarbock A. GDF-15 prevents platelet integrin activation and thrombus formation. J Thromb Haemost 2013; 11 (02) 335-344
    CrossrefPubMedGoogle Scholar
  • 25 Lippi G, Mattiuzzi C. The biomarker paradigm: between diagnostic efficiency and clinical efficacy. Pol Arch Med Wewn 2015; 125 (04) 282-288
    PubMedGoogle Scholar
  • 26 Lassila R. Platelet function tests in bleeding disorders. Semin Thromb Hemost 2016; 42 (03) 185-190
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56 (02) 254-261
    CrossrefPubMedGoogle Scholar
  • 28 Wollert KC, Kempf T, Giannitsis E. , et al. An automated assay for growth differentiation factor 15. J Appl Lab Med 2017; DOI: 10.1373/jalm.2016.022376.
    PubMedGoogle Scholar
  • 29 Levey AS, Stevens LA, Schmid CH. , et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150 (09) 604-612
    CrossrefPubMedGoogle Scholar
  • 30 Rohatgi A, Patel P, Das SR. , et al. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study. Clin Chem 2012; 58 (01) 172-182
    CrossrefPubMedGoogle Scholar
  • 31 Hagström E, Held C, Stewart RA. , et al; STABILITY Investigators. Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable coronary heart disease. Clin Chem 2017; 63 (01) 325-333
    CrossrefPubMedGoogle Scholar
  • 32 de Jager SC, Bermúdez B, Bot I. , et al. Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J Exp Med 2011; 208 (02) 217-225
    CrossrefPubMedGoogle Scholar
  • 33 Bonaterra GA, Zügel S, Thogersen J. , et al. Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury. J Am Heart Assoc 2012; 1 (06) e002550
    PubMedGoogle Scholar
  • 34 Fuchs I, Frossard M, Spiel A, Riedmüller E, Laggner AN, Jilma B. Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J Thromb Haemost 2006; 4 (12) 2547-2552
    CrossrefPubMedGoogle Scholar
  • 35 Małek ŁA, Spiewak M, Filipiak KJ. , et al. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes. Kardiol Pol 2007; 65 (01) 40-45 , discussion 46
    PubMedGoogle Scholar
  • 36 Hayes C, Kitahara S, Tcherniantchouk O. Decreased threshold of aggregation to low-dose epinephrine is evidence of platelet hyperaggregability in patients with thrombosis. Hematol Rep 2014; 6 (03) 5326
    PubMedGoogle Scholar
  • 37 Stec JJ, Silbershatz H, Tofler GH. , et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000; 102 (14) 1634-1638
    CrossrefPubMedGoogle Scholar
  • 38 Kaptoge S, Di Angelantonio E, Pennells L. , et al; Emerging Risk Factors Collaboration. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012; 367 (14) 1310-1320
    CrossrefPubMedGoogle Scholar
  • 39 de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 2010; 36 (01) 7-17
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008; 34 (08) 709-733
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Ho JE, Mahajan A, Chen MH. , et al. Clinical and genetic correlates of growth differentiation factor 15 in the community. Clin Chem 2012; 58 (11) 1582-1591
    CrossrefPubMedGoogle Scholar
  • 42 Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J. GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients. Int Urol Nephrol 2016; 48 (06) 839-844
    CrossrefPubMedGoogle Scholar
  • 43 Nair V, Robinson-Cohen C, Smith MR. , et al. Growth differentiation factor-15 and risk of CKD progression. J Am Soc Nephrol 2017; ASN.2016080919
    PubMedGoogle Scholar
  • 44 Sarnak MJ, Levey AS, Schoolwerth AC. , et al; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108 (17) 2154-2169
    CrossrefPubMedGoogle Scholar
  • 45 Salvagno GL, Pavan C. Prognostic biomarkers in acute coronary syndrome. Ann Transl Med 2016; 4 (13) 258
    CrossrefPubMedGoogle Scholar
  • 46 Jansen H, Koenig W, Jaensch A. , et al. Prognostic utility of galectin-3 for recurrent cardiovascular events during long-term follow-up in patients with stable coronary heart disease: results of the KAROLA study. Clin Chem 2016; 62 (10) 1372-1379
    CrossrefPubMedGoogle Scholar
  • 47 O'Donoghue ML, Morrow DA, Cannon CP. , et al. Multimarker risk stratification in patients with acute myocardial infarction. J Am Heart Assoc 2016; 5 (05) e002586
    CrossrefPubMedGoogle Scholar
  • 48 Montoro-García S, Hernández-Romero D, Jover E. , et al. Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy. Eur J Intern Med 2012; 23 (02) 169-174
    CrossrefPubMedGoogle Scholar
  • 49 Favaloro EJ. Clinical utility of closure times using the platelet function analyzer-100/200. Am J Hematol 2017; 92 (04) 398-404
    CrossrefPubMedGoogle Scholar
  • 50 Favaloro EJ. Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease. Am J Hematol 2017; 92 (01) 114-118
    CrossrefPubMedGoogle Scholar
  • 51 Harrison P, Keeling D. Platelet hyperactivity and risk of recurrent thrombosis. J Thromb Haemost 2006; 4 (12) 2544-2546
    CrossrefPubMedGoogle Scholar